1h Free Analyst Time
The pharmaceutical continuous manufacturing market is forecasted to grow by USD 548.94 mn during 2023-2028, accelerating at a CAGR of 12.74% during the forecast period. The report on the pharmaceutical continuous manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, evolving API manufacturing scenario in developing countries, and increasing adoption of sustainability in pharmaceutical industry.
The pharmaceutical continuous manufacturing market is segmented as below:
By Application
- Final drug product manufacturing
- API manufacturing
By Product
- Integrated systems
- Semi-continuous systems
- Controls or software
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the pharmaceutical continuous manufacturing market covers the following areas:
- Pharmaceutical continuous manufacturing market sizing
- Pharmaceutical continuous manufacturing market forecast
- Pharmaceutical continuous manufacturing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global pharmaceutical continuous manufacturing market: Chemtrix BV, Continuus Pharmaceuticals, Coperion GmbH, Corning Inc., Dr. Helmut Rothenberger Holding GmbH, Eli Lilly and Co., Freund Vector Corp., GE Healthcare Technologies Inc., GEA Group AG, Gebruder Lodige Maschinenbau GmbH, Gericke AG, Honeywell International Inc., Hosokawa Micron Corp., Hovione, KORSCH AG, L.B. Bohle Maschinen und Verfahren GmbH, LMT Group, Novartis AG, Pfizer Inc., Siemens AG, SK Inc., Syntegon Technology GmbH, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing digitalization and integration of industry 4.0 in continuous manufacturing.'
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Chemtrix BV
- Continuus Pharmaceuticals
- Coperion GmbH
- Corning Inc.
- Dr. Helmut Rothenberger Holding GmbH
- Eli Lilly and Co.
- Freund Vector Corp.
- GE Healthcare Technologies Inc.
- GEA Group AG
- Gebruder Lodige Maschinenbau GmbH
- Gericke AG
- Honeywell International Inc.
- Hosokawa Micron Corp.
- Hovione
- KORSCH AG
- L.B. Bohle Maschinen und Verfahren GmbH
- LMT Group
- Novartis AG
- Pfizer Inc.
- Siemens AG
- SK Inc.
- Syntegon Technology GmbH
- Thermo Fisher Scientific Inc.